AI in Healthcare

Is the FDA’s new AI regulation framework a step forward or a roadblock for healthcare innovation? As the global AI healthcare market surpasses $15 billion, this regulatory pause raises questions about whether it will protect patients or stifle the very innovations that could transform medicine. The stakes are high—especially as tools like generative AI begin to reshape everything from drug discovery to clinical trials. This critical juncture demands a reevaluation of how we govern AI in healthcare without stifling progress. Source: Framework for artificial intelligence implementation research in healthcare: synthesizing current evidence on barriers and facilitators | npj Digital Medicine · Published August 30, 2026 View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google & IBM-Trained. Cross Domain-Expert: Quantum, AI, Ethics, Sovereignty, Intelligence, Philanthropy. Solepoint Planning. VUI AI Cloud Architect. AI Certifications Development. Quant/AI Instructor. Castor Venture Club Member. Associate Broker. George Arnold Alexander III Director, ALEX Companies; Associate Broker, Alexander Tiffany Southwest, LLC. +1 713.918.9951 · [email protected]